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ABSTRACT 
Objective: To evaluate the hepato protective role of Heptoplus (HP), a ployherbal formulation as a supplementary agent for the Isoniazid and 
Rifampicin induced oxidative stress and apoptosis in liver.  
Methods: Liver cell lines were divided in to five groups. Group I is control, group II is treated with 30ng/ml of INH+RIF, group III, IV and V are 
supplemented with 50, 100 and 200 ng/ml of HP. At the end of the experimental period, biochemical tests for liver marker enzymes and antioxidant 
profile were studied. Gene expression for apoptosis and CYP2E1 was also studied.  
Result: Cells in group II suffer from severe oxidative stress and hepatotoxicity, as seen by significant decreases of (p≤0.001) reduced glutathione, 
catalase (p≤0.01) and superoxide dismutase (p≤0.001)  and significant increase (p≤0.01) of liver marker enzymes. However, liver cell lines 
nourished with 50, 100 and 200 ng/ml of HP were protected from oxidative stress and maintained normal antioxidant profile and liver marker 
enzymes in a dose dependent manner. Hepatocytes in group II, displayed significant (p≤0.001) up regulation of CYP2E1, BAX, P53 and caspases 3 
and significant (p≤0.001) down regulation of Bcl2 gene expression. Concomitant applications of HP protected the hepatocytes from programmed 
cell death by conserving normal CYP2E1expression and enhancing the protective action of Bcl2 by up regulating the expression on dose dependent 
manner.  
Conclusion: Heptoplus prevented oxidative stress and apoptosis, in hepatocytes. 
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INTRODUCTION  
Liver is playing a constitutive role in the maintenance and 
homeostasis of the body [1]. Though liver has paramount action on 
xenobiotics, it is the most susceptible organ for drug induced 
adverse effects, when compared to whole body. The overall 
incidence of drug induced liver injury in general population is 
greatly unknown, but the incidence of single drug induced 
hepatotoxicity is estimated between one in 1000 and 1 in 1laksh 
patients in a year for most of the drugs used in clinics [2, 3]. 
Isoniazid (INH) and Rifampicin (RIF) are the two prime 
chemotherapeutic agents used for the treatment of tuberculosis, 
however associated with hepatotoxicity [4]. Ubiquity of liver 
dysfunction is associated with both INH and RIF, used in 
combination [5]. In India, the occurrence of INH and RIF induced 
hepatotoxicity is 11.6 %, when compared to western countries 
where it is 4.3% [6]. Acetyl hydrazine and hydrazine are the 
metabolites of INH. Oxidative activation of these metabolites by 
cytochrome P450 system in the liver, results in the generation of 
electrophlic intermediates and free radicals, which are competent 
enough to induce liver injury [7, 8]. Moreover RIF is a powerful 
inducer of drug metabolising enzymes and exacerbate liver damage 
by enhancing the production of toxic metabolites from INH [9]. Both 
INH and RIF predominately impart oxidative stress to the liver by 
increasing lipid peroxidation (LPO) and suppressing the antioxidant 
profile, which is believed to be crucial event in the hepatotoxicity 
induction [10]. This paves the way for apoptosis [11]. Since oxidative 
stress and apoptosis are major events in INH and RIF induced 
hepatotoxicity, there is no constrictive treatment to treat liver 
toxicity. So herbal medicines are widely preferable choice of medical 
fraternity for their minimal side effects. Hence the present invitro 
study is designed to elucidate the role of HP as a supplementary 
agent for INH and RIF induced hepatotoxicity.  
MATERIALS AND METHODS  
Rifampicin and Isoniazid were procured from sigma chemicals and 
all other chemicals used for this study were analytical grade.  
Heptoplus  
Heptoplus is a polyherbal formulation drug, procured from Care and 
Cure Herbs pvt Ltd, Chennai, India, in the form of capsule. Each 
capsule has the following composition: PhyllanthusAmarus 100 mg, 
Eclipta Alba 50 mg, Tephrosia Purpurea 30 mg, Curcuma Longa 30 
mg, Picrrohiza Kurooa 20 mg, Withania Somnifera 100 mg, Pinius 
Succinifera (Amber) 37.50 mg, Pistacia Lentiscus 25 mg, Orchis 
Mascula 25 mg and Cycas Circinalis 62.50 mg. 
Culture of cells  
Chang liver cells, a type of human hepatoma cells were obtained 
from National Centre for Cell Science (NCCS), Pune, India. Cells were 
maintained in Minimum Essential Media (MEM) supplemented with 
10% Fetal Bovine Serum (FBS), with 100units/ml penicillin and 
100μg/ml streptomycin. Cells were cultured in 75 cm2 culture flasks 
and incubated at the humidified atmosphere with 5% CO2 at 37 °C. 
MTT assay  
Cell respiration as an indicator of cell viability and proliferation was 
determined by using a mitochondrial dependent reduction of 3-(4, 
5-dimethylthiazol-2-yl)-2, 5-Diphenyl tetrazolium bromide (MTT) to 
formazan. Preconfluent chang liver cells were seeded in 96-well 
plates at a density of 8, 000 cells/200μl/well. Cells were treated with 
different concentrations of the test drug [equal volume of INH+RIF 
and HP at concentrations ranging from 1X10-3-1X106 ng] after 24 h 
following plating and incubated at 37 °C for one day. At 20 h 
following drug exposure, the cells were incubated at 37 °C with 0.5 
mg/ml MTT for 4 h. At the end of the experiment, the medium was 
removed, and the insoluble formazan product was dissolved in 
DMSO (200μl) and kept at least 15 min in dark. The intensity of 
purple blue colour developed was measured at 570 and 630 nm 
using Thermo scientific multi scan spectrophotometer, USA. 
Percentage growth inhibitory rate of the test drug was calculated 
using the formula: 
% Growth inhibitory rate = ([Control OD–Test OD]/Control OD) * 100 
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Experimental protocol  
Chang liver cells were seeded in 6 well plates at a density of 1X105 
cells/well and allowed to grow for a period of 24 h for all treated 
groups. The study is divided in to five groups. 
Group I: Normal liver cells. 
Group II: liver cells treated with 30 ng/ml of INH and RIF. 
Group III: liver cells was exposed to 30ng/ml INH and RIF along with 
50 ng/ml of HP. 
Group IV: liver cells treated with 30ng/ml INH and RIF along with 
100ng/ml of HP. 
Group V: liver cells treated with 30ng/ml INH and RIF along with 
200ng/ml of HP. 
At the end of the exposure period, media was removed for 
biochemical estimation and the cells were trypsinised for measuring 
mRNA expressions of BAX, Bcl2, Caspase 3 and p53. 
Biochemical analysis of liver function marker enzymes  
At the end of the experiment period medium was used for the assay 
of aspartate transaminase (GOT) alanine transaminase (GPT), and 
alkaline phosphates (ALP) using accurex kit method. 
Antioxidant assay  
After the treatment period, medium was decanted and monolayer 
cells were washed twice with Hanks balanced salt solution twice. 
After that, cells were scrapped and dissolved in 1 ml of Tris HCl 
buffer and lysed completely using homogenizer. The homogenates 
were centrifuged at 3000 X g for 30 min at 40º c. The supernatant 
was used for the assay of catalase (CAT) [12], Superoxide dismutase 
(SOD)[13, 14] and reduced glutathione (GSH) [15].  
Polymerase chain reaction (RT-PCR) 
Total RNA was extracted using trizol Reagent (Sigma, USA). After 
homogenizing the cells with TRIzol reagent, the tubes were 
incubated for 10 min and centrifuged at 1000 rpm for 5 min. 200 µl 
of chloroform was added to the supernatant, allowed to incubate for 
5 min at room temperature and centrifuged at 12000 rcf for 20 min. 
Then 500 µl of isopropyl alcohol was added to the supernatant to 
precipitate the total RNA and centrifuged at 12000 rcf for 15 min 
following the incubation period of 10 min. The supernatant was 
decanted carefully; the pellet was washed thrice with 75% ethanol, 
centrifuged at 12000 rcf for 15 min. The pellet was air dried and 
then re-suspended in 20 µl of RNase free water and stored in-80 °C 
until use. RT-PCR was carried out using PCR master cycler gradient 
(Eppendorf, Germany) and semi-quantified using Bio1D software in 
gel documentation (Vilber Loumart, France): Oligonucleotide nested 
Primer sequences for GAPDH, apoptosis and CYP2E1genes were 
shown in table1. 
Data analysis 
Data was expressed as mean±SEM. Mean differences between the 
groups were analyzed by one way anova followed by turkey’s 
multiple comparison test using graph pad prism 5.0. p<0.05 was 
considered as statistically significant. 
RESULTS  
MTT assay 
MTT assay is used to determine the IC50 value of HP. Liver cells 
were treated with different concentrations of HP and INH+RIF for a 
period of 24 h. Liver cells were exposed to HP exhibited IC50 value 
of 315.6 ng/ml, whereas cell lines exposed to INH+RIF, IC50 value 
was 34.84 ng/ml. 
Effect of Heptoplus on biochemical markers of liver function 
Biochemical markers for liver functions were carried out, in order to 
study the efficacy and pharmacological actions of HP, the results 
obtained are shown in table-2. In Group II, liver cells showed significant 
increases of (p<0.001) AST, ALT, ALP and LDH, when compared to group 
I liver cells. However, hepatocytes in group V show near normal levels of 
AST, ALT, ALP and LDH. Hepatocytes in group III and IV show dose 
dependent decreases in liver function enzymes. 
  
Table 1: Oligonucleotide nested primer sequences for GAPDH, apoptosis and CYP2E1genes 
Primer Forward primer Reverse primer 
GAPDH 5’-CGACAGTCAGCCGCATCTT-3’ 5’-CCAATACGACCAAATCCGTTG-3’ 
BAX 5'-TTTTGCTTCAGGGTTTCATC-3' 5'-GACACTCGCTCAGCTTCTTG-3' 
BCL2 5'-ATGTGTGTGGAGAGCGTCAACC-3' 5'-TGAGCAGAGTCTTCAGAGACAGCC-3' 
Caspase 3 5′-AATTCAAGGGACGGGTCATG-3′ 5′-GCTTGTGCGCGTACAGTTTC-3′ 
P53 5'-GGATGCCCGTGCTGCCGAGGAG-3' 5'-AGTGAAGGGACTAGCATTGTC-3' 
CYP2E1 5'-TCAATCTCT GGACCCCAACTG-3'  5'-GCGCTCTGCACTGTGCTTT-3' 
 
Table 2: In vitro hepatoprotecive effect of Heptoplus on isoniazid and rifampicin induced toxicity 
 Parameters Group I Group II Group III Group IV Group V 
AST U/l 124.6±2.1 198.7±6.7***  172.5±1.9 b 144.6±3.9 c 125.6±3.1ac 
ALT U/l 85.68±3.2 201.6±2.0***  178.6±1.5 c 103.8±3.3 c 89.85±2.8a c 
ALP U/l 192.1±3.2 413.4±6.8***  312.6±2.1 c  218.9±5.7 c  201.4±1.6 c 
LDH U/l 177.9±6.0 303±9.6*** 252±3.5b 216.9±8.6 c 188.0±6.8 c a 
Values are expressed as mean±SEM where N=3. P is ≤ 0.05 *, ≤ 0.01** and ≤0.001*** vs group I. P is ≤ 0.01 b and ≤0.001c vs group II. P is ≤ 0.05a 
group IV vs V. 
 
Effect of Heptoplus on antioxidant profile 
The homeostatic effect of HP on antioxidant profile status of INH and RIF 
treated liver cells were analysed; the results are shown in the table-3. 
Liver cells in group II, show significant (p<0.01) decrease of CAT, SOD 
and GSH, when compared to group I. At the same time, the hepatocytes 
in group IV and V, show significant elevation of CAT, SOD and GSH in a 
dose dependent manner, when compared to group II. In the group III, 
liver cells show minimal changes, when compared to group I. 
Effect of Heptoplus on CYP2E1 and apoptosis gene expression 
Fig.1 shows the effect of HP on apoptotic and CYP2E1 m RNA 
expressions in the chang liver cellines. The effect HP on CYP2E1 m 
RNA expression is shown in fig.2 Hepatocytes treated with INH and 
RIF, show significant (p<0.01) upregulation of CYP2E1gene 
expression, when compared to normal group I hepatocytes. 
However, HP supplemented cells in group IV and V show 
significant down regulation of CYP2E1 m RNA expression in a 
dose dependent manner, when compare to group II liver cells. 
The effect on HP on BAX gene expression was analysed and 
shown in fig.3. Cells in group II shows significant (p<0.001) 
upregulation of Bax gene expression, when compared to group I 
cells. Cells in group III, IV and V shows down regulation of BAX 
gene expression in a dose dependent manner, when compared to 
group II liver cells. 
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Table 3: In vitro antioxidant activity of Heptoplus on isoniazid and rifampicin induced oxidative stress 
parameters Group I Group II Group III Group IV Group V 
GSH nmol/104 cells 4.63±0.1 2.80±0.2 *** 3.43±0.2  3.67±0.0 a 4.30±0.1c# 
CAT H202 nm/min/mg protein 23.59±1.2 16.06±0.9 ** 17.69±0.8 19.62±0.3 22.28±1.2b# 
SOD units/mg protein 8.82±0.2 5.68±.0.3 *** 5.93±0.2 7.46±0.3#b 8.57±0.2c### 
Values are expressed as mean±SEM where N= 3. P is 0.05 *, ≤ 0.01** and ≤0.001*** vs group I, P is ≤ 0.05 a, ≤ 0.01b and ≤0.001c vs group II. P is ≤ 
0.05# and ≤ 0.001###group III vs group V. 
 
The semi quantitative analysis of m RNA expression of caspases 3 
and P53 are shown in fig.4 and fig.5 Significant upregulation of both 
caspases 3 and p53 m RNA expression, was observed in the cells 
exposed to INH and RIF. However, cells supplemented with HP show 
significant down regulation of caspases 3 and p53 m RNA 
expressions, when compared to group II hepatocytes. Bcl2 mRNA 
gene expression is shown in fig.6. Liver cell lines in group II shows 
significant down regulation of Bcl2 m RNA expression, when 
compared to group I control. Liver cell lines treated with HP in 
group III, IV and V shows significant upregulation of Bcl2 expression, 
when compared to groupII cells.  
 
 
Fig. 1: Effects of Heptoplus on isoniazid and rifampicin induced 
apoptosis and CYP2E1 gene expression in hepatocytes 
Lane 1 control hepatocytes, lane 2 heptocytes exposed to INH and 
RIF treated, lane 3 hepatocyes supplemented with 50 ng/ml of HP, 
lane 4 liver cell lines exposed to 100 ng/ml of HP and lane 5 treated 
with 200 ng/ml of HP 
 
Fig. 2: Effect of Heptoplus on isoniazid and rifampicin induced 
CYP2E1 gene expression in hepatocytes 
Values are expressed as mean±SEM, where N=3. P is≤0.001*** vs 
group II. P is ≤0.01band≤0.001c vs group I. P is ≤ 0.05#group IV vs 
group V. 
 
Fig. 3: Effect of Heptoplus on isoniazid and rifampicin induced 
proapoptotic BAX gene expression in hepatocytes 
Values are expressed as mean±SEM, where N=3. P is ≤0.001*** vs 
group II. P is ≤0.001c vs group I. P is ≤ 0.001###group IV vs group V. 
 
 
Fig. 4: Effect of Heptoplus on isoniazid and rifampicin induced 
caspases 3 gene expression in hepatocytes 
Values are expressed as mean±SEM, where N=3. P is ≤0.001*** vs 
group II. 
P is ≤0.01band ≤0.001c vs group I. P is ≤ 0.05#group IV vs group V. 
 
 
Fig. 5: Effect of Heptoplus on isoniazid and rifampicin induced 
p53 gene expression in hepatocytes 
Values are expressed as mean±SEM, where N=3. P is ≤ 0.05 *, ≤ 
0.01** and ≤0.001*** vs group II. 
P is ≤0.001c vs group II. P is ≤ 0.001###group IV vs group V. 
 
 
Fig. 6: Modulative effect of Heptoplus on Bcl 2 gene expression 
in hepatocytes 
Values are expressed as mean±SEM, where N=3. P is ≤ 0.01** and 
≤0.001*** vs group II. P is ≤ 0.01band ≤0.001c vs group I. P is ≤ 
0.01##group IV vs V. 
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DISCUSSION 
One of the profound concerns of using INH and RIF for the treatment 
of tuberculosis is hepatotoxicity [16]. Particularly oxidative stress is 
the attributing mechanism of INH and RIF induced liver damage 
[17]. During oxidative insult free radicals generated from the 
reactive metabolites of RIF and INH, initiate peroxidative 
degradation of membrane lipids, which in turn promote the 
formation of lipid peroxides. As a result malondialdehyde (MDA) is 
generated, which leads to loss of integrity of cell membrane [18]. 
Hepatocyte integrity is appraised by the presence of liver enzymes 
like, AST, ALT and ALP levels in the systemic circulation [19]. 
Aberrant index of AST and ALT in the cell supernatant, indicate the 
presence of hepatocyte damage. HP application reduces these maker 
enzymes in the supernatant by curtailing the generation of lipid 
peroxides and maintaining the membrane integrity of hepatocytes. 
LDH is localized in the cytoplasm of cell, which exudates in to 
systemic circulation during cell damage or necrosis. Measurement of 
LDH is used as an index of necrosis [20]. Sharp increases in LDH, 
denotes the presence of necrotic cells. HP applications prevented the 
necrosis in the hepatocytes and allowing to maintain normal LDH 
levels. GSH is a crucial endogenous antioxidant, which scavenges 
reactive oxygen intermediates (ROS) and maintains the intracellular 
redox balance and protect tissue from oxidative insult [21]. 
Treatment of INH and RIF disturbs overall antioxidant/pro oxidant 
balance in the hepatocytes, by generating ROS and imparting 
oxidative stress in the tissue [22]. In the present study the drastic 
reduction of GSH, might be due to the maximum utilization for 
detoxification. Supplementation of HP restores the hepatic GSH 
content by neutralizing the ROS. Liver is guarded with the presence 
of innate antioxidant enzymes like SOD and CAT. Nevertheless a 
reduction in the activity of these enzymes in the cell, results in the 
accumulation of free radicals, which pave the way for loss of 
integrity of the membrane and its function [23]. Both CAT and SOD 
are mutual antioxidant enzymes, easily inactivated by the presence 
of ROS or lipid peroxides [24]. Decline of CAT and SOD activities in 
the hepatocytes, may lead to ROS and lipid peroxide mediated 
injures. HP treatment restores the activities of CAT and SOD in 
hepatocytes. Thus it curtails the generation of lipid peroxidation by 
neutralizing the ROS. CYP2E1 is responsible for the metabolism of 
both INH and RIF in the liver. The pathogenicity of INH and RIF 
induced liver injury is a consequence of reactive metabolite 
hydrazine formed during the biotransformation reaction, which in 
turns results in the generation of ROS and carbonyl compounds. 
Moreover RIF aggravates hepatotoxicity by enhancing production of 
toxic metabolites from INH, by inducing CYP2E1 [25]. Upregulation 
of CYP2E1 expression is a sign of oxidative stress. HP treatment 
protected the hepatocytes from the oxidative insult by regulating the 
CYP2E1 gene expression. Bcl-2 is an antiapoptotic factor, normally 
displayed in the outer mitochondrial membrane to inhibit apoptosis. 
During oxidative stress, BAX pro-apoptosis marker migrates to the 
power house of cell and inhibits the protective effect of Bcl-2 [26]. 
Up regulation of BAX and down regulation of Bcl-2 expression, is a 
symbol of mitochondria mediated apoptosis pathway. HP 
application prevents mitochondria mediated apoptosis by 
maintaining normal Bcl2 protective action. P[53] is a sequence 
specific transcription factor, activated in response to internal and 
external stimuli. When the cell is under severe stress, the activated 
P53 translocates from the nucleus and modulates the action of Bcl2 
and BAX on the mitochondrial membrane, resulting in activation of 
effectors caspases; inducing cell death [27]. In the present study 
upregulation of P[53] and effectors caspases denote the triggering of 
apoptosis, due to oxidative stress. HP nourishment restrains 
hepatocyte from apoptosis by modulating the expression of P53 and 
effector caspases.  
CONCLUSION 
From this in vitro study, the liver cell lines supplemented with 
Heptoplus protected the hepatocytes from oxidative stress and 
resultant apoptosis, which is induced by INH and RIF, in a dose 
dependent manner. 
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